نتایج جستجو برای: wbrt

تعداد نتایج: 475  

Journal: :Japanese journal of clinical oncology 2009
Koji Matsumoto Masashi Ando Chikako Yamauchi Chiyomi Egawa Yasushi Hamamoto Masaaki Kataoka Takashi Shuto Kumiko Karasawa Masafumi Kurosumi Norimichi Kan Michihide Mitsumori

OBJECTIVE A nationwide survey was performed to investigate the current patterns of care for brain metastasis (BM) from breast cancer in Japan. METHOD A total of 351 survey questionnaires were sent to community or academic breast oncologists who were members of the Japanese Breast Cancer Society as of December 2005. The questionnaire consists of 40 multiple choice questions in eight categories...

Journal: :American journal of physiology. Heart and circulatory physiology 2011
Junie P Warrington Anna Csiszar Daniel A Johnson Terence S Herman Salahuddin Ahmad Yong Woo Lee William E Sonntag

Whole brain radiation therapy (WBRT) leads to cognitive impairment in 40-50% of brain tumor survivors following treatment. Although the etiology of cognitive deficits post-WBRT remains unclear, vascular rarefaction appears to be an important component of these impairments. In this study, we assessed the effects of WBRT on the cerebrovasculature and the effects of systemic hypoxia as a potential...

2014
Yun Hwa Jung Chi Wha Han Yun Duk Jung Young Yun Cho Deok Jae Han

Brain parenchymal metastasis from a solid tumor is a serious clinical condition associated with a poor outcome because systemic chemotherapy is usually ineffective for treating brain metastases (BM) due to the blood-brain barrier. Therefore, radiotherapy such as whole brain radiotherapy (WBRT) and stereotactic radiosurgery have taken on a central role in the management of BM. However, WBRT can ...

2012
Nicholas C. Bambakidis

Background: Relapse after whole-brain radiation therapy (WBRT) for multiple cerebral metastases occurs fairly often and is associated with a poor prognosis. Re-irradiation is an option that many defer because of risks of exceeding brain tolerance and resulting toxicity. Objective: To determine if brain re-irradiation is beneficial. Design: Single-institution retrospective study. Methods: Patien...

Journal: :Current Oncology 2008
J. Wong A. Hird A. Kirou–Mauro J. Napolskikh E. Chow

BACKGROUND An estimated 20%-40% of cancer patients will develop brain metastases. Whole-brain radiotherapy (WBRT) is the standard treatment for patients with brain metastases. Although WBRT can reduce neurologic symptoms, the median survival following WBRT is between 3 and 6 months. Given this limited survival, it is important to consider quality of life (QOL) when treating patients with brain ...

Journal: :International journal of radiation oncology, biology, physics 2013
Junko Ebi Hisashi Sato Masaru Nakajima Fumio Shishido

PURPOSE To evaluate the incidence of leukoencephalopathy after whole-brain radiation therapy (WBRT) in patients with brain metastases. METHODS AND MATERIALS We retrospectively reviewed 111 patients who underwent WBRT for brain metastases from April 2001 through March 2008 and had evaluable computed tomography (CT) and/or magnetic resonance imaging (MRI) at least 1 month after completion of WB...

Journal: :International journal of radiation oncology, biology, physics 2012
Christina H Son Rachel Jimenez Andrzej Niemierko Jay S Loeffler Kevin S Oh Helen A Shih

PURPOSE Patients with brain metastases are often treated with whole brain radiation therapy (WBRT) for purposes of palliation. The treatment of those who experience subsequent intracranial disease progression can include a second course of WBRT, although there is controversy surrounding its safety and efficacy. This study examines the outcomes in patients at Massachusetts General Hospital who u...

2016
Yongshun Chen Jing Yang Xue Li Daxuan Hao Xiaoyuan Wu Yuanyuan Yang Chunyu He Wen Wang Jianhua Wang

We proposed to compare the outcomes of first-line epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) alone with EGFR-TKI plus whole-brain radiotherapy (WBRT) for the treatment of brain metastases (BM) in patients with EGFR-mutated lung adenocarcinoma. A total of 1665 patients were screened from 2008 to 2014, and 132 were enrolled in our study. Among the 132 patients, 72 (54.5...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2014
C Lévy D Allouache J Lacroix A E Dugué S Supiot M Campone M Mahe S Kichou M Leheurteur C Hanzen V Dieras Y Kirova F Campana E Le Rhun L Gras T Bachelot M-P Sunyach I Hrab J Geffrelot K Gunzer J-M Constans J-M Grellard B Clarisse X Paoletti

BACKGROUND Brain metastases (BMs) are associated with a poor prognosis. Standard treatment comprises whole-brain radiation therapy (WBRT). As neo-angiogenesis is crucial in BM growth, combining angiogenesis inhibitors such as bevacizumab with radiotherapy is of interest. We aimed to identify the optimal regimen of bevacizumab combined with WBRT for BM for phase II evaluation and provide prelimi...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2006
Elizabeth W Newcomb Sandra Demaria Yevgeniy Lukyanov Yongzhao Shao Tona Schnee Noriko Kawashima Li Lan J Keith Dewyngaert David Zagzag William H McBride Silvia C Formenti

PURPOSE High-grade glioma treatment includes ionizing radiation therapy. The high invasiveness of glioma cells precludes their eradication and is responsible for the dismal prognosis. Recently, we reported the down-regulation of MHC class I (MHC-I) products in invading tumor cells in human and mouse GL261 gliomas. Here, we tested the hypothesis that whole-brain radiotherapy (WBRT) up-regulates ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید